D. Huber

Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial

T. Mooe, Stina Jakobsson, Fredrik Björklund, 2016, BMC Cardiovascular Disorders.

Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival

R. Henriksson, T. Mooe, Stina Jakobsson, 2016, Trials.

Risk factors for pulmonary arterial hypertension in children and young adults

L. Söderström, E. Naumburg, I. Axelsson, 2017, Pediatric pulmonology.

Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial

R. Henriksson, T. Mooe, D. Huber, 2021, Scientific Reports.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Some neonatal risk factors for adult pulmonary arterial hypertension remain unknown

L. Söderström, E. Naumburg, I. Axelsson, 2015, Acta paediatrica.